Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cytokinetics Inc (CYTK) vs Mesoblast Limited (MESO) Price & Performance

Cytokinetics IncTrade
Mesoblast LimitedTrade

Price performance (Past 24H)

Key statistics

Cytokinetics Inc vs Mesoblast Limited — how do they compare? Cytokinetics Inc trades at $76.67 (market cap $10.63B), while Mesoblast Limited trades at $16.68 (market cap $2.21B). The key difference: Cytokinetics Inc is far larger — about 4.8× Mesoblast Limited's market cap, and Cytokinetics Inc is trading nearer its 52-week high, Mesoblast Limited nearer its low. Which is the better fit depends on your goals.

CYTKMESO
Market Cap
$10.63B$2.21B
Sector
TechnologyTechnology
52-Week High
$87.26$20.96
52-Week Low
$34.31$12.88
Enterprise Value
$10.74B$2.21B

Returns comparison

Trailing returns across standard periods

About Cytokinetics Inc

Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.

Read more on CYTK

About Mesoblast Limited

Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.

Read more on MESO